Riskpilot← Back to searchSign inGet full accessAM Lemke AB
ABActiveOrg 5591070338Köpstadsvägen 27Business and other management consultancy activities · NACE 7020Est. 20171-4 employees
Revenue 2024
SEK 1M
+114% vs 2023
EBITDA margin
3.9%
+116% vs 2023
Equity ratio
78.3%
Financial strength
Net profit 2024
SEK 541K
+371% vs 2023
| Revenue | SEK 1M | +114% |
| EBITDA | SEK 40K | +116% |
| Net profit | SEK 541K | +371% |
| Total assets | SEK 779K | +82% |
| Equity | SEK 610K | +128% |
| Employees | — | — |
Legal name
AM Lemke AB
Org number
5591070338
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
30 mars 2017
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget skall bedriva konsultverksamhet inom logistik och projektledning samt bedriva handel med värdepapper, äga och förvalta andelar i andra bolag samt annan därmed förenlig verksamhet.
Address
Köpstadsvägen 27
Email
anders.severinsson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 111 | 121 | 1 239 | 483 | 1 036 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 298 | −263 | 342 | −244 | 40 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 298 | −263 | 342 | −244 | 40 |
| Net financials | — | — | −162 | 1 | 501 |
| Profit before tax | 223 | −187 | 218 | −200 | 541 |
| Tax | −49 | −0 | −27 | −0 | −0 |
| Net profit | 174 | −187 | 191 | −200 | 541 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 696 | 374 | 686 | 428 | 779 |
| Equity | 464 | 277 | 468 | 268 | 610 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 156 | 97 | 175 | 159 | 170 |
| Total debt | 156 | 97 | 175 | 159 | 170 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20202024
Equity ratio
78.3%
This company
38.2%
Market median
+105% vs market
20202024
Return on equity
88.7%
This company
18.4%
Market median
+382% vs market
20202024
Net profit margin
52.2%
This company
8.1%
Market median
+544% vs market
20202024
Asset turnover
1.33×
This company
1.12×
Market median
+19% vs market
20202024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AM Lemke AB 
Prismakliniken ABBoard members of AM Lemke AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Therese Frie | Deputy Board Member | 0 companies |
| Sven Anders Severinsson | Board of Directors | 0 companies |
| Anna Marina Alwine Lemke | Chairman | 0 companies |